Clinical Trials on Rhinoconjunctivitis

Total 141 results

ALK-Abelló A/S

Completed

A Trial Evaluating Tolerability of Grazax Treatment in Combination With Antihistamine (GT-19)

Allergic Rhinoconjunctivitis

Germany
ClinNovis GmbH

Completed

Validation of a Combined Symptom and Medication Score in Patients Suffering From Allergic Rhinoconjunctivitis

Rhinoconjunctivitis, Allergic

Germany
BioTech Tools S.A.

Completed

Clinical Safety and Tolerability Study of gpASIT+TM and gpASIT+TM/Immunoregulating Adjuvant to Treat Seasonal Grass Pollen Rhinoconjunctivitis

Seasonal Allergic Rhinoconjunctivitis

Belgium
University of Zurich

Completed

Study to Assess the Clinical Efficacy and Safety of a Novel Method of Specific Allergen Immunotherapy in Grass Pollen Allergic Subjects by Epicutanous Allergen Administration

Rhinoconjunctivitis

Switzerland
Roxall Medicina España S.A

Completed

A Clinical Trial With Subcutaneous Immunotherapy in Depot Presentation in Patients With Rhinoconjuncitivis Sensitized to Olea Europaea

Rhinoconjunctivitis

Spain
ALK-Abelló A/S

Completed

Avanz Phleum Pratense Maintenance Dose

Allergic Rhinoconjunctivitis

Germany
Medical University of Graz

Recruiting

Nasal Mucus Proteome and Immunotherapy

Allergic Rhinoconjunctivitis

Austria
Immunomic Therapeutics, Inc.

Completed

A Safety and Immunogenicity Phase IB Study of CryJ2-DNA-Lysosomal Associated Membrane Protein (CryJ2 -DNA-LAMP) Plasmid Assessing the Long Term Safety of Previously Treated Subjects

Allergic Rhinoconjunctivitis

United States
University of Zurich

Completed

Study of Specific Allergen Immunotherapy in Grass Pollen Allergic Subjects With Epicutanoeus Allergen Administration (ZU-SkinSIT-003)

Allergic Rhinoconjunctivitis

Switzerland
ALK-Abelló A/S

Completed

An Open Trial to Assess the Tolerability of AVANZ Phleum Pratense Immunotherapy

Allergic Rhinoconjunctivitis

Spain
ALK-Abelló A/S

Completed

An Open Trial to Assess the Tolerability of AVANZ® Cupressus Immunotherapy

Allergic Rhinoconjunctivitis

Spain
Immunomic Therapeutics, Inc.

Completed

A Safety and Immunogenicity Phase I Study of CryJ2-DNA-Lysosomal Associated Membrane Protein (CryJ2 -DNA-LAMP) Plasmid

Allergic Rhinoconjunctivitis

United States
Cytos Biotechnology AG

Completed

A Study to Investigate an Immunomodulatory Therapy in Adult Patients With Perennial Allergic Rhinoconjunctivitis

House Dust Mite Allergy | Perennial Allergic Rhinoconjunctivitis

Switzerland
Cytos Biotechnology AG

Completed

A Study to Investigate an Immunomodulatory Therapy in Adult Patients With Perennial Allergic Rhinoconjunctivitis

House Dust Mite Allergy | Perennial Allergic Rhinoconjunctivitis
Allergopharma GmbH & Co. KG
Inflamax Research Incorporated

Terminated

Evaluation of the Utility of an EEC for Assessing Efficacy of SIT in Pivotal Clinical Trials

Healthy Volunteers | Allergic Rhinoconjunctivitis

Canada
ALK-Abelló A/S

Completed

A Survey of Adults and Children With Allergic Rhinoconjunctivitis (MK-7243-021) (AIRS)

Allergic Rhinoconjunctivitis
Laboratorios Leti, S.L.

Completed

Efficacy-safety Study of Sublingual Immunotherapy With Depigmented-polymerized Pollen Extracts to Treat Rhinoconjunctivitis (GPIT)

Allergic Rhinoconjunctivitis

South Africa
University Hospital, Antwerp
DSM Nutritional Products, Inc.

Completed

Probiotic Chewables in Allergic Rhinoconjunctivitis Patients

Allergic Rhinoconjunctivitis

Belgium
Artu Biologicals

Completed

Efficacy and Safety of Grass Pollen Sublingual Immunotherapy

Allergic Rhinoconjunctivitis

Bulgaria, Lithuania, Czech Republic, Germany, Hungary, Netherlands, Slovakia
Artu Biologicals

Unknown

A Randomised, Double-blind, Placebo Controlled Study With Oralgen Grass Pollen Rhinoconjunctivitis

Allergic Rhinoconjunctivitis

Netherlands, United Kingdom, Germany, Poland, Belgium, France
NTC srl

Completed

Efficacy and Safety of Lertal® as an add-on to Standard Therapy for Allergic Rhinoconjunctivitis in Pediatrics

Allergic Rhinoconjunctivitis

Italy
Roxall Medicina España S.A

Completed

Clinical Trial With Subcutaneous Immunotherapy in Depot Presentation in Patients With Allergic Rhinoconjunctivitis Sensitized to House Dust Mites

Allergic Rhinoconjunctivitis

Spain
Allergopharma GmbH & Co. KG

Completed

Dose Range Finding Study With rBet v1-FV - in Adult Patients With Birch Pollen-Allergic Seasonal Rhinoconjunctivitis

Allergic Rhinoconjunctivitis

Germany
Artu Biologicals

Completed

Long-term Efficacy and Safety Study With Oralgen Grass Pollen

Allergic Rhinoconjunctivitis

Bulgaria, Lithuania, Czech Republic, Germany, Hungary, Netherlands, Slovakia
Roxall Medicina España S.A

Completed

Dose-response Study With Subcutaneous Immunotherapy of an Standardized Dermatophagoides Pteronyssinus (DPT) Extract

Allergic Rhinoconjunctivitis

Spain
Roxall Medicina España S.A

Completed

Phase II Trial With Subcutaneous Immunotherapy in Patients Sensitized to Phleum Pratense

Allergic Rhinoconjunctivitis

Spain, Portugal
Circassia Limited
Cetero Research, San Antonio; Adiga Life Sciences, Inc.

Completed

ToleroMune House Dust Mites (HDM) Exposure Chamber Study

Rhinoconjunctivitis

Canada
BioTech Tools S.A.

Completed

Safety Study of Grass Pollen-derived Peptides to Treat Seasonal Allergic Rhinoconjunctivitis

Seasonal Allergic Rhinoconjunctivitis

Belgium
Allergopharma GmbH & Co. KG

Completed

Multicenter Trial of Sublingual Immunotherapy With a Solution of Grass Pollen Allergen Extract in Children

Allergic Rhinoconjunctivitis

Germany
Allergopharma GmbH & Co. KG

Completed

Immunological and Histological Evaluation of Specific Immunotherapy With Recombinant Hypoallergenic Derivative

Allergic Rhinoconjunctivitis

Sweden
ALK-Abelló A/S

Completed

An Open Trial to Assess the Tolerability of AVANZ® Salsola Immunotherapy (AV-X-02)

Allergic Rhinoconjunctivitis Due to Salsola Kali Pollen

Spain
Roxall Medicina España S.A

Completed

Subcutaneous Immunotherapy in Patients Sensitized to Dermatophagoides Pteronyssinus (DPT)

Allergic Rhinoconjunctivitis

Spain
Roxall Medicina España S.A

Completed

Study for Evaluating Life Quality in Patients With Rhinoconjunctivitis (ÍCARA)

Allergic Rhinoconjunctivitis

Spain
Novartis

Completed

Efficacy and Safety of Intraseasonal Specific Immunotherapy With Depiquick® Birch (INSIDE)

Allergic Rhinoconjunctivitis

Germany
ALK-Abelló A/S

Terminated

A Research Study in Chinese People With Allergy to House Dust Mites, Using an Environmental Exposure Chamber (QUEST)

Allergic Rhinoconjunctivitis

Austria, China
National Polytechnic Institute, Mexico
Instituto de Oftalmología Fundación Conde de Valenciana

Completed

Quality of Life in Allergic Rhinoconjunctivitis Patients Treated With Dialyzable Leukocyte Extracts

Allergic Rhinoconjunctivitis
ALK-Abelló A/S

Completed

Tolerability of Grazax in Patients With Hayfever in Real Life Settings (GRAAL)

Allergic Rhinoconjunctivitis

France
Circassia Limited
Adiga Life Sciences, Inc.; Topstone Research

Completed

An Optional Investigation of Biomarkers of Efficacy

Rhinoconjunctivitis

Canada
Laboratorios Leti, S.L.

Completed

Subcutaneous Immunotherapy Treatment for Patients With Hypersensitivity to Parietaria Judaica

Allergic Rhinoconjunctivitis

Spain
Roxall Medicina España S.A

Completed

A Trial With Subcutaneous Immunotherapy (SCIT) in Patients With Rhinoconjunctivitis Sensitized to Olea Europaea and Phleum Pratense

Rhinoconjuntivitis

Spain
Stallergenes Greer

Completed

Safety and Efficacy on Phase III Study on 300 IR SLIT to Patients Suffering From Grass Pollen Rhinoconjunctivitis

Primary Disease

France, Italy, Spain
Circassia Limited
Adiga Life Sciences, Inc.

Completed

ToleroMune Grass Follow on Study

Grass Allergy | Rhinoconjunctivitis

Canada
Circassia Limited
Adiga Life Sciences, Inc.; Cetero Research, Toronto

Completed

An Optional Two Year Follow Up Study to Study CP005A

Cat Allergy | Rhinoconjunctivitis

Canada
Circassia Limited
Cetero Research, San Antonio; Adiga Life Sciences, Inc.

Completed

ToleroMune Ragweed Follow up Study

Rhinoconjunctivitis | Ragweed Allergy

Canada
Circassia Limited
Cetero Research, San Antonio; Adiga Life Sciences, Inc.

Completed

Cat-PAD Follow on Study

Cat Allergy | Rhinoconjunctivitis

Canada
Allergy Therapeutics
Ecarf Institute GmbH; Bencard Allergie GmbH

Completed

Effect of holoBLG on Cat Allergic Patients

Allergic Rhinoconjunctivitis | Allergy to Cats

Germany
Circassia Limited
Adiga Life Sciences, Inc.; Pharm-Olam International

Completed

ToleroMune Grass Follow on Study

Grass Allergy | Rhinoconjunctivitis
Circassia Limited
Adiga Life Sciences, Inc.

Completed

Ragweed-SPIRE Follow-On Study

Rhinoconjunctivitis | Ragweed Allergy

Canada
Circassia Limited
Adiga Life Sciences, Inc.; Pharm-Olam International

Completed

ToleroMune Grass Exposure Unit Study

Grass Allergy | Rhinoconjunctivitis

Canada
ORA, Inc.

Completed

A Pilot Study Evaluating the Signs and Symptoms of Seasonal Allergic Rhinoconjunctivitis Following Exposure in the Allergen BioCube

Allergic Rhinoconjunctivitis

United States

Clinical Trials on Rhinoconjunctivitis

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Uruguay

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations